The Chain of Gastrointestinal Recovery; Remove-Replace-Reinnoculate-Repair

 

Remove, Replace, Reinnoculate, Repair, the 4R Program, is a strategic sequence of therapies designed to help re-establish normal gastrointestinal function.

*The first component, Removal of pathenogenic organisms (e.g., parasites, allergens, dysbiosis) supports a normal intestinal environment, removes a primary source of metabolic toxins, and aids the efficacy and comfort of subsequent steps.

*As the second component of the 4R Program, Replacement of necessary digestive factors (such as pancreatic and intestinal enzymes, hydrochloric acid, intrinsic factor, and bile) and gradually increasing fiber intake support normal digestion. 

Cranial respiratory faults must be evaluated and corrected if present, because of their capacity to shut down the normal acid production in the stomach through diminished nerve signal through Cranial Nerve X.  This lack of stomach acid production reduces the pH necessary in the small intestine to signal the pancreas to release digestive enzymes.

*After Removal of metabolic toxin sources and Replacement of digestive factors, the digestive tract may be Reinnoculated with beneficial flora to re-establish a more functional environment. Not all flora are alike, however.

To be considered a probiotic, an organism should be able to:

Survive host defenses like bile salts, digestive enzymes, and digestive acids; adhere to intestinal mucosal cells (inhibiting colonization by pathogens).

Produce substances that help maintain a healthy microbial balance (such as organic acids and peroxides). Among the few organisms confirmed to have these three qualities are Lactobacillus acidophilus strain NCFM®, L. casei strain Shirota, and L.  rhamnosus strain GG (“Lacto GG”, formerly L. casei).

In addition, probiotics produce beneficial short-chain fatty acids in the intestines, and may stimulate specific and non-specific host immune responses. The term “symbiotic” has been recently applied to co-administered probiotic and prebiotic substances.

Stabilized human probiotic strains like L. acidophilus strain may support immune function in healthy as well as hypersensitive individuals. In contrast, phagocyte receptor expression increases in non-dairy-sensitive individuals receiving this strain. A recent study of atopic infants found symptomatic improvement and lower inflammatory marker levels in treated infants. Though confirmatory studies are needed, lactic acid bacteria (lactobacilli and some bifidobacteria) have shown diverse effects on intestinal immune function.  These include beneficial effects on microbial balance, decreased intestinal permeability, and improved lactose tolerance.

 

*The fourth step of the 4R program is Repair of the digestive system lining, or gut wall.  The enterotrophic effects of glutamine are well known, but recent evidence shows that it may help reduce intestinal permeability among those using nonsteroidal anti-inflammatory drugs (NSAIDs). Subjects pretreated with high doses of glutamine or given multiple doses of glutamine near the time of NSAID administration retained greater intestinal barrier function than those given only the NSAID. Subjects given a synthetic prostaglandin in addition to glutamine and NSAID did even better.

Another study suggests that, in protein-deficient guinea pigs, supplemental zinc helps normalize intestinal barrier function and hypersensitivity to cow’s milk. Malnourished animals show greater intestinal oxidation and sensitivity in response to cow’s milk, and supplemental zinc may support intestinal barrier function in these animals.

Supplemental fiber (Ultrabalance Herbulk- a Metagenics Product) may also be needed by the gut during the Repair phase, as intestinal fermentation of soluble fibers produces butyric, propionic, and acetic acids, providing key nutrition for enterocytes and colonocytes. In animals, fiber supplementation may help restore barrier function of the small intestine and colon after chemotherapy. Enteric nutrition alone did not preserve intestinal structure and function in chemotherapy-treated animals, but those additionally given fiber showed less bacterial translocation, less intestinal atrophy, and lower intestinal permeability.

Each serving of UltraClear Sustain® provides glutamine, zinc, inulin, fructooligosaccharides, and other dietary fibers for specialized dietary support of enterocytes and colonocytes. For further product information: Glutagenics combines glutamine with standardized aloe leaf extract and concentrated deglycyrrhizinized licorice extract.

Glutamine is the major free amino acid in the body, and it is a preferred fuel by enterocytes and many types of immune cells. It is additionally used for acid-base balance, gluconeogenesis, and synthesis of nucleotides, glutathione, histidine, Krebs cycle intermediates, and amino sugars.

Skeletal muscle can ‘donate’ glutamine as a nitrogen source for connective tissue healing or metabolically exchange it for branched-chain amino acids, which are skeletal muscle’s preferred fuels. Glutamine availability is particularly crucial during healing, acidosis, inflammation, chronic stress, steroid use, or other increased metabolic demand, during which it may become essential. Glutamine depletion after strenuous exertion is strongly linked to greater immune susceptibility.

Glutamine may have even more specialized roles in controlling the life cycles of epithelial and immune cells lining the digestive tract. It ‘nurses’ immature epithelial cells, supporting their early growth and differentiation, and depriving enterocytes of glutamine results in their premature death. Glutamine may also support normal cell life cycles in stressed intestinal cells, as irradiated rats given glutamine maintain better intestinal barrier function and villous structure than those not given glutamine.

Because ammonia is a common conversion product of glutamine, glutamine supplementation may not be suitable for those with compromised kidney or liver function.

References:

Darmon N, Pelissier MA, Candalh C, et al. Zinc and intestinal anaphylaxis to cow’s milk proteins in malnourished guinea pigs. Pediatr Res. 1997;42(2):208-213.

Hond DE, Peeters M, Hiele M, Bulteel V, Ghoos Y, Rutgeerts P. Effect of glutamine on the intestinal permeability changes induced by indomethacin in humans. Aliment Pharmacol Ther. 1999;13(5):679-685.

Deng GY, Liu YW, He GZ, Jiang ZM. Effect of dietary fiber on intestinal barrier function of 5-Fu stressed rats. Res Exp Med (Berl). 1999;199(2):111-119.

Castell LM, Newsholme EA. Glutamine and the effects of exhaustive exercise upon the immune response. Can J Physiol Pharmacol. 1998;76:524-532.

Kingsbury KJ, Hjelm M. Contrasting plasma free amino acid patterns in elite athletes: association with fatigue and infection. Br J Sports Med. 1998;32(1):25-32.

Rowbottom DG, Keast D, Garcia-Webb P, Morton AR. Training adaptation and biological changes among well-trained male triathletes. Med Sci Sports Exerc. 1997;29(9):1233-1239.

Rohde T, Krzywkowski K, Pedersen BK. Glutamine, exercise, and the immune system-is there a link? Exerc Immunol Rev. 1998;4:49-63.

Papaconstantinou HT, Hwang KO, Rajaraman S, Hellmich MR, Townsend CM, Ko TC. Glutamine deprivation induces apoptosis in intestinal epithelial cells. Surgery. 1998;124(2):152-159.

Chun H, Sasaki M, Fujimaya Y, Bamba T. Effect of enteral glutamine on intestinal permeability and bacterial translocation after abdominal radiation injury in rats. J Gastroenterol. 1997; 32:189-195.

Pelto L, Isolauri E, Lilius EM, Nuutila J, Salminen S. Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin Exp Allergy. 1998;28(12):1474-1479.  ASM News. Probiotics gaining recognition. June 2000.

Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 2000;130:396S-402S.  Gorbach SL. Probiotics and gastrointestinal health. Am J Gastroenterol.

2000;95(1 Suppl):S2-S4.

Wagner RD, Pierson C, Warner T, et al. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice.  1997;65(10):4165-4172.

Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol. 1997;9(2):179-185.